Ibiglustat (Venglustat) L-Malic acid is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat L-Malic acid can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease
In Vitro
Ibiglustat (SAR402671) (1 μM, 15 days) L-Malic acid treated Fabry disease (FD) cells are close to the physiological level in untreated WT cells in GL-3 levels, suggesting that Ibiglustat L-Malic acid can prevent additional GL-3 accumulation and could serve to ameliorate the abundant levels of this sphingolipid in FD cardiomyocytes . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
IC50& Target:Glucosylceramide synthase
规格
别名
伊比鲁司特(L-苹果酸)
规格或纯度
10mM in DMSO
英文名称
Ibiglustat (L-Malic acid)
生化机理
Ibiglustat(文格鲁他)L-苹果酸是一种口服活性、脑渗透性葡萄糖酰胺合成酶(GCS)抑制剂。Ibiglustat L-Malic acid can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry d